Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betahistine for antipsychotic-associated weight and metabolic measures in schizophrenia
IRCT20191223045870N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Betahistine adjunct arm with Placebo adjunct arm (2 arms). Primary endpoints: Weight, Waist circumference and 6 more. Started Jun 2020; status: completed.
02
Drugs
betahistine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20191223045870N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191223045870N1.